IndiaTickerAnalysts/Institutional Investor Meet/Con. Call Updates - Solara Active Pharma Sciences LimitedNSE · conference call · pdf
Source filing Company dossier
Solara Active Pharma Sciences
NSE:SOLARA · ISIN INE624Z01016
- Close
- ₹506.2 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Solara Active Pharma Sciences
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Copy of Newspaper Publication - Solara Active Pharma Sciences LimitedNSE · financial results · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Updates - Solara Active Pharma Sciences LimitedNSE · financial results · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Submission Of Machine Readable Copy Of Financial Results For The Quarter Ended June 30, 2026BSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Solara Active Pharma Sciences LimitedNSE · conference call · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · audio
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Monitoring Agency Report - Solara Active Pharma Sciences LimitedNSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Monitoring Agency ReportBSE · exchange filing · pdf
Source filing Statement of deviation(s) or variation(s) under Reg. 32 - Solara Active Pharma Sciences LimitedNSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended June 30, 2026.BSE · corporate action · pdf
Source filing ESOP/ESOS/ESPS - Solara Active Pharma Sciences LimitedNSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSBSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Intimation About Appointment Of Chief Information Officer (CIO)BSE · exchange filing · pdf
Source filing Press Release - Solara Active Pharma Sciences LimitedNSE · exchange filing · pdf
Source filing General Updates - Solara Active Pharma Sciences LimitedNSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Unaudited Financial Results For The Quarter Ended June 30, 2026BSE · financial results · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30, 2026.BSE · financial results · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Solara Active Pharma Sciences LimitedNSE · financial results · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('Listing Regulations')BSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Solara Active Pharma Sciences LimitedNSE · conference call · pdf
Archived filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Solara Active Pharma Sciences LimitedNSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Solara Active Pharma Sciences LimitedNSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing General Updates - Solara Active Pharma Sciences LimitedNSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Approval Of The Reminder - Cum - Forfeiture NoticeBSE · corporate action · pdf
Source filing General Updates - Solara Active Pharma Sciences LimitedNSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Solara Active Pharma Sciences LimitedNSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · corporate action · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Transfer Of Equity Shares Of The Company To The IEPFBSE · corporate action · pdf
Source filing Trading Window - Solara Active Pharma Sciences LimitedNSE · exchange filing · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Credit Rating - Solara Active Pharma Sciences LimitedNSE · credit rating · pdf
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Source filing